During the past decade, AOU Integrata conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "AOU Integrata" #1 collaborator was "Azienda Policlinico Umberto I" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "AOU Integrata" are "Cytomegalovirus Viremia" (1 trials), "Hematologic Diseases" (1 trials), "Herpesvirus Infection" (1 trials), "Myeloid Malignancies" (1 trials) and "Stem Cell Transplant Complications" (1 trials). Many other conditions were trialed in "AOU Integrata" in a lesser frequency.

Most popular intervention types in "AOU Integrata" are "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "GvHD prophylaxis" (1 trials). Other intervention names were less common.

The vast majority of trials in "AOU Integrata" are 2 trials for "All" genders.

Currently, there are NaN active trials in "AOU Integrata". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in AOU Integrata, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in AOU Integrata, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".